Hydrops fetalis is a serious condition in which abnormal fluid builds up in two or more compartments of an unborn baby’s body, such as around the heart, around the lungs, in the abdomen, or beneath the skin.1The Obstetrician & Gynaecologist. Non‐immune hydrops fetalis: a practical guide for obstetricians The fluid accumulation is not a disease in itself but a visible sign that something deeper has gone wrong with the baby’s circulation, blood production, or lymphatic drainage. The underlying cause can range from blood-type incompatibility between mother and baby to genetic abnormalities, infections, heart rhythm problems, and structural defects, and the cause determines both the treatment path and the outlook.
Why the Fetal Body Is Prone to Fluid Buildup
Fluid constantly moves between blood vessels and the surrounding tissue in every human body. Normally, the lymphatic system drains excess fluid back into the bloodstream fast enough to prevent swelling. In a fetus, that balance is much more fragile than in an adult. Fetal capillaries are more permeable, meaning fluid leaks out more easily. The surrounding tissue is more compliant, so it stretches to accommodate extra fluid rather than creating back-pressure that would slow the leak. And fetal lymphatic vessels are more sensitive to changes in venous pressure, so anything that raises pressure in the veins can slow lymphatic return significantly.2PubMed. Pathophysiology of hydrops fetalis All of this means a fetus can tip into visible fluid overload from insults that an older child or adult could compensate for without trouble.
The practical consequence is that many different problems funnel into the same endpoint. Severe anemia, heart failure, blocked lymphatic channels, low blood protein levels, and infections can all push fetal fluid production above what the lymphatic system can clear. Because so many roads lead to the same visible result on ultrasound, identifying which road got there is the central challenge when hydrops is found.
Immune Versus Non-Immune Causes
Historically, the most common cause was Rh incompatibility, where the mother’s immune system produces antibodies that attack the baby’s red blood cells. This is called immune hydrops. When a mother’s blood type is Rh-negative and the baby’s is Rh-positive, the mother can develop antibodies that cross the placenta, destroy fetal red blood cells, and cause severe anemia. Widespread use of Rh immune globulin (commonly known as the RhoGAM shot) over the past several decades has dramatically reduced immune hydrops, though it has not eliminated it entirely.
Rh is not the only blood-group mismatch that can cause trouble. Antibodies to less common red-cell antigens sometimes slip through standard screening. One documented case involved antibodies to the Kpa antigen, a target so uncommon that the screening cells used to investigate an earlier pregnancy’s hydrops were negative for it, meaning the antibody was missed entirely.3PubMed Central. Hydrops fetalis caused by a blood group antibody usually undetected in routine screening Any mismatch between maternal and fetal red-cell antigens can trigger an immune response that ranges from mild anemia to full-blown hydrops.4PubMed Central. Hemolytic disease of the fetus and newborn due to minor blood group alloimmunization in a mother of sickle cell disease with multiple alloantibodies
Because Rh disease has become rarer, the vast majority of hydrops cases seen today are non-immune, meaning they are not caused by maternal antibodies. Non-immune hydrops fetalis can result from genetic conditions, congenital anomalies, infections, fetal heart rhythm problems, placental tumors, complications of identical twins sharing a placenta, and a range of rarer disorders.5Wiley Online Library / Pregnancy. Society for Maternal-Fetal Medicine Consult Series #75: Evaluation and management of non-immune hydrops fetalis The sheer number of possible causes makes diagnosis a painstaking process.
Genetic Causes
Genetic abnormalities are among the most frequent explanations for non-immune hydrops. Chromosome-level problems like Turner syndrome, trisomy 21 (Down syndrome), and trisomy 18 are well-known culprits. In one study evaluating the genetics of non-immune cases, abnormal karyotypes included Turner syndrome, trisomy 21, trisomy 18, and a chromosome inversion, while targeted gene sequencing identified cases of Noonan syndrome and a lymphatic disorder caused by variants in the PIEZO1 gene.6PubMed Central. Nonimmune hydrops fetalis: identifying the underlying genetic etiology
In Down syndrome, hydrops sometimes develops because the fetus has abnormal blood cell production in the liver, a condition that leads to an enlarged liver and spleen along with fluid buildup.7Ultrasound in Obstetrics and Gynecology. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: A sign of myeloproliferative disorder in fetuses with trisomy 21 In Turner syndrome, defective lymphatic development is the primary mechanism. In Noonan syndrome, both cardiac defects and lymphatic abnormalities can contribute.
A growing body of work shows that when standard chromosome testing comes back normal, deeper genetic analysis with exome sequencing can identify a single-gene disorder in a substantial number of remaining cases. A prospective study found that exome sequencing identified disease-causing genetic variants in about a third of the non-immune hydrops cases it was applied to, and an underlying diagnosis of some kind was reached in half of all cases overall. Genetic disorders accounted for roughly two-thirds of all diagnosed cases.8PubMed. Enhancing Diagnostic Precision in Non-Immune Hydrops Fetalis: The Incremental Value of Whole Exome Sequencing-A Prospective Cohort Study The practical upshot is that genetics explains more non-immune hydrops than most other single category of cause, and advanced sequencing is increasingly used when initial testing is unrevealing.
Infections That Cause Hydrops
Human parvovirus B19, the virus behind “fifth disease” or “slapped cheek” disease in children, is the best-known infectious cause. In an adult, parvovirus B19 usually causes a mild rash or joint aches. In a fetus, the virus targets red blood cell precursors in the bone marrow, temporarily shutting down red cell production and causing profound anemia.9PubMed. Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection The fetal heart tries to compensate by pumping faster and harder, but if the anemia is severe enough, heart failure and hydrops follow. Early research demonstrated that viral DNA could be found in multiple fetal tissues, confirming direct in-utero infection.10PubMed. Human parvovirus infection in pregnancy and hydrops fetalis
The encouraging aspect of parvovirus-related hydrops is that some cases resolve on their own once the fetus’s bone marrow recovers. In more severe cases, intrauterine transfusion can bridge the gap. Other infections implicated in hydrops include cytomegalovirus, toxoplasmosis, syphilis, and occasionally other viral or parasitic infections, though parvovirus B19 remains the most common infectious trigger.
Blood Disorders and Alpha-Thalassemia
Any condition that causes severe fetal anemia can produce hydrops, and inherited hemoglobin disorders are a significant category, especially in Southeast Asian and Mediterranean populations. Homozygous alpha-thalassemia (Bart hydrops fetalis syndrome), in which the fetus inherits four deleted alpha-globin genes, is one of the most severe forms. Without any functional alpha-globin, the fetus cannot make normal hemoglobin, and the resulting anemia is typically fatal without intervention.
Related alpha-globin variants can also cause significant fetal anemia. In a series of cases involving homozygous Hemoglobin Constant Spring and similar alpha-globin variants, fetal anemia was diagnosed between 20 and 34 weeks of pregnancy, with initial blood counts showing very low red cell volumes. All cases underwent intrauterine transfusions without serious complications.11Journal of Pediatric Hematology/Oncology. Fetal Anemia Causing Hydrops Fetalis From an Alpha-Globin Variant: Homozygous Hemoglobin Constant Spring These cases illustrate that carrier screening before or early in pregnancy can flag couples at risk and allow for early monitoring.
Cardiac Arrhythmias and Heart Failure
A fetus with a sustained abnormal heart rhythm can develop heart failure and hydrops remarkably quickly. The most common culprit rhythms are supraventricular tachycardia, where the heart rate runs far above normal, and atrial flutter. Because the fetal heart is small and the circulatory system has little reserve, a fast rhythm that an adult could tolerate for hours can overwhelm a fetus within days.
Treatment involves giving the mother medications that cross the placenta and slow or reset the baby’s heart rhythm. Digoxin has been the traditional first choice, but evidence suggests it works less well when hydrops has already developed, likely because the fluid accumulation impairs how the drug crosses into the fetal circulation. Flecainide and sotalol are alternatives that appear more effective in hydropic fetuses.12PubMed Central. First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis In one case report, a combination of sotalol and digoxin successfully treated a fetus with supraventricular tachycardia and hydrops.13PubMed Central. Successful medical treatment of fetal supraventricular tachycardia that cause hydrops fetalis In a review of 21 patients treated with sotalol, normal heart rhythm was established in most fetuses with atrial flutter and more than half of those with supraventricular tachycardia.14PubMed. Sotalol in the treatment of fetal dysrhythmias Rhythm-related hydrops tends to have a better prognosis than many other causes, precisely because the underlying problem is treatable.
Lymphatic and Thoracic Problems
Congenital chylothorax, a condition in which lymphatic fluid accumulates in the chest cavity, can develop from abnormalities in the lymphatic vessels themselves or from structural defects in the chest. The fluid buildup squeezes the developing lungs and compromises both heart and lung function, and it can lead to hydrops. Reassuringly, many cases of congenital chylothorax eventually resolve on their own, even without detailed imaging to pinpoint the exact lymphatic defect.
When fluid in the chest is large enough to cause hydrops, drainage is sometimes necessary before birth. A thoracoamniotic shunt, a tiny tube placed through the mother’s abdomen and the uterus into the baby’s chest cavity, allows the fluid to drain continuously into the surrounding amniotic fluid. In one series, hydrops resolved after shunt placement in about four out of five affected fetuses, with overall survival around two-thirds.15PubMed. Thoracoamniotic shunts for the management of fetal lung lesions and pleural effusions: a single-institution review and predictors of survival in 75 cases Another study reported roughly similar survival figures for shunting in the setting of pleural effusion with hydrops, with premature delivery being the main source of complications afterward.16PubMed. Thoracoamniotic shunting for fetal pleural effusions with hydrops A smaller series demonstrated that all fetuses had successful chest decompression, lung re-expansion, and hydrops resolution, with all pregnancies reaching at least 30 weeks.17PubMed Central. Percutaneous In Utero Thoracoamniotic Shunt Creation for Fetal Thoracic Abnormalities Leading to Non-Immune Hydrops
How Hydrops Is Detected and Evaluated
Most cases are first spotted on a routine ultrasound, which shows the telltale fluid collections. Once hydrops is identified, the diagnostic workup fans out to search for the cause. Blood typing and an antibody screen in the mother come first to rule out immune causes. If the antibody screen is negative, the investigation shifts to non-immune territory.
One of the most useful non-invasive tools is Doppler measurement of blood flow in the baby’s middle cerebral artery. When a fetus is anemic, blood becomes thinner and flows faster, and the peak velocity in this artery rises in a predictable way. A measurement above a certain threshold has been shown to detect moderate to severe fetal anemia with very high sensitivity and a low false-positive rate.18Fetal Diagnosis and Therapy. Elevated Middle Cerebral Artery Peak Systolic Velocity in Non-Anemic Fetuses: Providing a Better Understanding of Enigmatic Middle Cerebral Artery Peak Systolic Velocity In the specific context of non-immune hydrops, this same measurement helps sort out whether anemia is driving the problem or whether another mechanism is at work.19PubMed. Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops
When more information is needed, invasive procedures come into play. Amniocentesis can retrieve fetal cells for chromosome analysis and infection testing. Cordocentesis, in which a needle samples blood directly from the umbilical cord, provides a complete blood count, blood chemistry, and karyotype in one step and has been used to diagnose conditions like Down syndrome presenting with hydrops and low blood counts.20PubMed. Fetal hydrops and anemia as signs of Down syndrome If initial genetic testing is unrevealing, exome sequencing can be offered for a deeper look at single-gene disorders.
Intrauterine Transfusion for Anemia-Driven Hydrops
When the cause is severe fetal anemia, whether from immune destruction, parvovirus, or a hemoglobin disorder, intrauterine transfusion is the primary treatment. A needle guided by ultrasound delivers red blood cells directly into the umbilical vein. In one landmark series of 26 fetuses with severe immune-related disease, 20 of whom already had hydrops, the overall survival rate was about four in five. Among those who survived, hydrops completely resolved in the majority.21American Journal of Obstetrics and Gynecology. The reversal of hydrops fetalis by intravascular intrauterine transfusion in severe isoimmune fetal anemia
More recent experience confirms the safety of the procedure. A 14-year single-center review covering 135 transfusions in 56 fetuses reported no fetal or neonatal deaths. Mild complications occurred in about one in ten procedures, and severe complications in fewer than two in a hundred, though the presence of hydrops was associated with a higher risk of adverse events.22PubMed Central. Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven For anemia caused specifically by parvovirus, survival with intrauterine transfusion has been reported in the range of two-thirds to three-quarters of cases.23PubMed Central. Intrauterine transfusion in hydropic fetuses: An outcome analysis
Mirror Syndrome and Risks to the Mother
Hydrops fetalis is primarily a fetal condition, but it can affect the mother in a striking way known as mirror syndrome (or Ballantyne syndrome). The mother’s body begins to mirror the baby’s fluid-overloaded state, developing swelling, high blood pressure, low blood protein, and sometimes protein in the urine. The clinical picture closely resembles preeclampsia, and the underlying mechanism is thought to involve similar widespread damage to the lining of blood vessels.24PubMed Central. Clinical presentation and maternal-fetal outcomes of Mirror Syndrome: A case series of 10 affected pregnancies
A systematic review found that maternal swelling appeared in virtually all cases, high blood pressure in roughly two-thirds to three-quarters, and protein in the urine in about a fifth to over half. Severe complications such as fluid in the mother’s lungs occurred in about one in five affected pregnancies. Maternal symptoms generally disappeared within about one to two weeks after delivery.25Fetal Diagnosis and Therapy. Mirror Syndrome: A Systematic Review of Fetal Associated Conditions, Maternal Presentation and Perinatal Outcome Mirror syndrome is rare, but recognizing it matters because its management sometimes requires delivery even when the fetus is premature, and distinguishing it from preeclampsia itself can be difficult.
Long-Term Outcomes for Survivors
Survival depends heavily on what caused the hydrops in the first place. Treatable causes like fetal arrhythmias and parvovirus-related anemia carry a much better prognosis than chromosomal abnormalities or severe structural malformations. Among liveborn babies with non-immune hydrops, one long-term follow-up study found that those with pleural effusions had a notably lower survival rate, around a quarter, compared with about three-fifths of those without pleural effusion. Among survivors who made it past the first year of life, roughly two-thirds showed normal development, while a smaller proportion had mild or moderate delays. Severe developmental problems were concentrated among babies who were born very early and at very low birth weight.26PubMed. Long-term outcome of 51 liveborn neonates with non-immune hydrops fetalis
The message from outcome data is that hydrops itself is not a sentence. When the cause is identified and treated before or immediately after birth, many children go on to develop normally. But the window for intervention is often narrow, and the outcomes for untreated or untreatable causes remain poor.
When Genetic Testing Cannot Be Done Before Birth
In cases where hydrops results in fetal loss or neonatal death without a clear diagnosis, postmortem evaluation can still provide critical information. A molecular autopsy using exome sequencing of the baby and both parents identified disease-causing genetic variants in a quarter of hydrops cases studied, alongside higher rates for other structural anomaly categories.27PubMed Central. Molecular autopsy by trio exome sequencing (ES) and postmortem examination in fetuses and neonates with prenatally identified structural anomalies This kind of testing can transform an unexplained loss into a diagnosis that changes how the family approaches future pregnancies.
Knowing the specific genetic cause makes recurrence-risk counseling concrete rather than speculative. If the variant arose for the first time in the baby, the chance of recurrence in a future pregnancy is very low, around one percent, driven only by the small possibility that one parent carries the variant in a subset of their reproductive cells. If both parents are carriers of a recessive condition, the risk for each future pregnancy is one in four. If a parent carries a dominant condition, the risk can be as high as one in two.28Genetics in Medicine. High diagnosis rate for nonimmune hydrops fetalis with prenatal clinical exome from the Hydrops-Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) Study Families armed with that information can pursue early prenatal testing or preimplantation genetic testing in subsequent pregnancies.
Perinatal Palliative Care
Not all cases of hydrops have a treatable cause. When the underlying diagnosis is a condition incompatible with long-term survival, families face difficult decisions about continuing the pregnancy, the level of medical intervention after birth, and how to spend the time they have. A perinatal palliative care team provides a space to work through those decisions, drawing on each family’s values, faith, and goals. Some families choose to pursue every available medical intervention. Others prioritize comfort-focused care to maximize the time they can spend together. Still others find reassurance in waiting for a postnatal confirmatory diagnosis before deciding on the intensity of care.29PubMed Central. Decisions Parents Make When Faced With Potentially Life-Limiting Fetal Diagnoses and the Importance of Perinatal Palliative Care The availability of palliative support varies between hospitals, but awareness of this option is growing, and families facing a hydrops diagnosis with a poor prognosis should know it exists.